A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anjulika Chawla, MD, FAAP
bluebird bio, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Children'S National Hospital
Washington D.C., District of Columbia, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Duke University
Durham, North Carolina, United States
- Baylor College of Medicine/texas Children'S Hospital
Houston, Texas, United States
- Virginia Commonwealth University (vcu)
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Feb 2020
- Primary completion
- 31 May 2027
- Completion
- 30 Nov 2027
- Last update posted
- 10 Dec 2024
- Registered enrollment
- 35
- Registry id
- NCT04293185
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.